This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Protein Crystal Growth (PCG) | |
|---|---|
| Name | Protein Crystal Growth |
| Caption | Schematic of macromolecular crystallization |
| Field | Structural biology |
| Known for | X-ray crystallography, cryo-electron microscopy |
Protein Crystal Growth (PCG)
Protein Crystal Growth concerns formation of ordered macromolecular lattices used to determine three-dimensional structures. Originating from early work in macromolecular chemistry, PCG underpins major achievements in X-ray crystallography, Nobel Prize–winning discoveries and structural campaigns at facilities such as European Molecular Biology Laboratory, Brookhaven National Laboratory, and Lawrence Berkeley National Laboratory. Research in PCG intersects with initiatives at institutions like Howard Hughes Medical Institute, Max Planck Society, and companies such as Genentech.
Crystallization of proteins enables structural determination by techniques developed and refined at sites including Royal Institution, Cold Spring Harbor Laboratory, and MRC Laboratory of Molecular Biology. Key historical milestones involved investigators at University of Cambridge, California Institute of Technology, and University of Oxford whose work complemented efforts at Brookhaven National Laboratory and Los Alamos National Laboratory. Major awards from bodies such as the Royal Society and the National Academy of Sciences have recognized advances stemming from successful crystal growth campaigns.
Protein crystallization relies on principles articulated in foundational texts inspired by researchers at Massachusetts Institute of Technology, Yale University, and Harvard University. Core concepts include supersaturation, nucleation, and growth driven by intermolecular interactions studied by teams at Princeton University, University of Chicago, and Columbia University. Thermodynamic and kinetic frameworks draw on theories developed by scholars at California Institute of Technology and Stanford University, while molecular packing motifs relate to structural catalogs maintained at Protein Data Bank and curated by partners such as RCSB PDB and European Bioinformatics Institute.
Common methods such as vapor diffusion, microbatch, and dialysis were formalized in protocols from laboratories at University of Washington, Imperial College London, and University of Pennsylvania. High-throughput screening approaches were implemented at centers like Diamond Light Source, SLAC National Accelerator Laboratory, and Argonne National Laboratory. Robotic crystallization platforms produced by vendors collaborating with Pfizer, Roche, and Novartis enable automated trials. Complementary techniques including seeding, hanging drop, sitting drop, and microfluidic chips were advanced through projects at ETH Zurich, EPFL, and Karolinska Institutet.
Protein purity, buffer composition, precipitants, additives, and temperature are critical variables explored by investigators at University of California, San Francisco, Johns Hopkins University, and Duke University. Specific precipitants such as polyethylene glycol and salts were studied in work involving Merck and academic groups at University of Illinois Urbana-Champaign. Ligand binding, post-translational modifications, and construct design influence crystallizability; such strategies originate from labs at University of Texas Southwestern Medical Center and Scripps Research. Environmental control methods applied at facilities like Brookhaven National Laboratory and European Synchrotron Radiation Facility help manage nucleation and growth.
Characterization integrates diffraction experiments at synchrotrons including ESRF, SSRL, and APS with electron microscopy at centers such as National Center for Electron Microscopy. Data processing pipelines developed by consortia including CCP4, Phenix, and AutoProc support structure solution efforts led by groups at University of Cambridge and University of Oxford. Complementary spectroscopic analyses traceable to work at Argonne National Laboratory and Lawrence Livermore National Laboratory refine understanding of lattice order and defect states. Cryogenic techniques used at European Molecular Biology Laboratory and Riken reduce radiation damage during data collection.
Protein crystals have enabled drug discovery programs at GlaxoSmithKline, AstraZeneca, and Bristol Myers Squibb and informed vaccine design efforts at Moderna and Pfizer. Structural insights from crystallography guided enzyme engineering in collaborations between Dow Chemical Company and academic partners at University of California, Berkeley. Crystallographic outcomes supported by initiatives at NIH, Wellcome Trust, and Bill & Melinda Gates Foundation have influenced public health and biotechnology pipelines. Industrial applications extend to materials science groups at MIT and Sandia National Laboratories exploring biomolecular assemblies.
Challenges include obtaining well-ordered crystals for membrane proteins and complexes; breakthroughs from groups at Rockefeller University, Weizmann Institute of Science, and Tokyo Institute of Technology advance methodologies. Limitations due to radiation damage, disorder, and polymorphism are mitigated by cryo-cooling protocols developed at Argonne National Laboratory and serial femtosecond crystallography using X-ray free-electron lasers at LCLS and European XFEL. Recent advances in integrative structural biology combine data from cryo-electron microscopy, NMR spectroscopy, and crystallography informed by computational modeling at DeepMind and initiatives at European Bioinformatics Institute.
Category:Structural biology